News
-
-
-
PRESS RELEASE
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
BioNxt Solutions Inc. announces a large-mass animal bioequivalence study for sublingual Cladribine formulation, targeting multiple sclerosis treatment, to optimize dosage parameters for upcoming human study -
-
PRESS RELEASE
Administrative and Cultural Experts from Craft Cities around the World Heading to Cheongju
Administrative and cultural experts from craft cities worldwide gather at Cheongju Craft Biennale for World Craft Expert Forum to explore urban development centered on craft economies, with over 50 international delegates -
-
-
-
-
PRESS RELEASE
EQS-Adhoc: MBB SE increases EBITDA by 80% to €67.4 million in the third quarter and raises its forecast to €1.1-1.2 billion in revenue with an EBITDA margin of 15-17%
MBB SE increases EBITDA by 80% to €67.4 million in Q3, raising revenue forecast to €1.1-1.2 billion with EBITDA margin 15-17%. Company achieves strong operating performance
